Siga technologies, inc.SIGA.US Overview

US StockHealthcare

(No presentation for SIGA)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

SIGA Overall Performance

SIGA AI Analysis & Strategy

SIGA Recent Performance

-0.11%

Siga technologies, inc.

0.81%

Avg of Sector

-1.14%

S&P500

SIGA PowerScanner

SIGA Key Information

SIGA Valuation Metrics

SIGA Earnings Table

SIGA Profile

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.